The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Andrea M. Pless
Advertisement
Andrea M. Pless is an associate director at Teva
Articles by Andrea M. Pless
A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.
Advertisement
Latest Updated Articles
Evaluating Progress in Analytical Quality by DesignApril 2nd 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Updates Master Protocol: What Developers Need to Know
2
Pharma Fundamentals: Hold Times in Biopharmaceuticals
3
Merck KGaA Launches Saturnus Bio; Announces Awards
4
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
5